mefenamic acid and mk 0663

mefenamic acid has been researched along with mk 0663 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Ranong, CN; Sukcharoen, N1
Jamil, MA; Mahdy, ZA; Maryasalwati, I; Nor Azlin, MI; Norzilawati, MN; Zainul Rashid, MR1

Trials

2 trial(s) available for mefenamic acid and mk 0663

ArticleYear
Analgesic effect of etoricoxib in secondary dysmenorrhea: a randomized, double-blind, crossover, controlled trial.
    The Journal of reproductive medicine, 2007, Volume: 52, Issue:11

    Topics: Adult; Analgesia; Analgesics; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Dysmenorrhea; Etoricoxib; Female; Humans; Mefenamic Acid; Placebos; Pyridines; Sulfones; Treatment Outcome

2007
The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial.
    Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2008, Volume: 28, Issue:4

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Dysmenorrhea; Etoricoxib; Female; Humans; Mefenamic Acid; Pyridines; Sulfones

2008

Other Studies

1 other study(ies) available for mefenamic acid and mk 0663

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013